Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:711-713
doi: 10.1161/CIRCULATIONAHA.107.188520
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2008;117:711-713.)
© 2008 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Cell Therapy for Modification of the Myocardial Electrophysiological Substrate
 
Cardiac arrhythmias account for significant worldwide morbidity and mortality. Preventive antiarrhythmic therapies are aimed at modifying the abnormal electrophysiological substrate by either focal injury (surgery or radiofrequency catheter ablation) or pharmacological therapy. Antiarrhythmic drug therapy has been hampered by often low efficacy, global cardiac and systemic actions that often lead to poorly tolerated systemic side effects, and most important, life-threatening proarrhythmic effects. In this study, we present a novel combined cell and gene therapy approach for the modification of the myocardial electrophysiological substrate. Using fibroblast cell grafts genetically engineered to express specific potassium ionic channels, we aimed to perform a targeted modification of local cardiac electrophysiological properties. Detailed in vitro, in vivo, and computer modeling studies demonstrated the feasibility of this approach by showing that the engineered cells could couple with host cardiac cells and that this modified their electrophysiological properties. The cell grafts modulated important properties that are of interest for future antiarrhythmic strategies. These include prolongation of the local refractory period by a mechanism that does not involve action potential prolongation (potentially reducing the proarrhythmic risk associated with many antiarrhythmic agents that prolong the QT interval) and reduction in local automaticity (decreasing the spontaneous firing rate). See p 720.


*    Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression
 
Vascular thrombi develop in the presence of reduced blood velocities, when the activity of the clotting system is increased, and in the presence of endothelial alterations (Virchow’s triad). Virchow’s triad also applies to atrial thrombus formation during atrial fibrillation (AF). It is well known that AF causes loss . . . [Full Text of this Article]


Related Articles:

Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients
Alanna Coolong, Donald S. Baim, Richard E. Kuntz, A. James O’Malley, Sachin Marulkar, Donald E. Cutlip, Jeffrey J. Popma, and Laura Mauri
Circulation 2008 117: 790-797. [Abstract] [Full Text]

Cell Therapy for Modification of the Myocardial Electrophysiological Substrate
Lior Yankelson, Yair Feld, Tal Bressler-Stramer, Ilanit Itzhaki, Irit Huber, Amira Gepstein, Doron Aronson, Shimon Marom, and Lior Gepstein
Circulation 2008 117: 720-731. [Abstract] [Full Text]

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
Ralph B. D’Agostino, Sr, Ramachandran S. Vasan, Michael J. Pencina, Philip A. Wolf, Mark Cobain, Joseph M. Massaro, and William B. Kannel
Circulation 2008 117: 743-753. [Abstract] [Full Text]

Oral Buflomedil in the Prevention of Cardiovascular Events in Patients With Peripheral Arterial Obstructive Disease: A Randomized, Placebo-Controlled, 4-Year Study
Limbs International Medicinal Buflomedil (LIMB) Study Group
Circulation 2008 117: 816-822. [Abstract] [Full Text]

Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study
Pamela L. Lutsey, Lyn M. Steffen, and June Stevens
Circulation 2008 117: 754-761. [Abstract] [Full Text]

Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice
Miina K. Öhman, Yuechun Shen, Chinyere I. Obimba, Andrew P. Wright, Mark Warnock, Daniel A. Lawrence, and Daniel T. Eitzman
Circulation 2008 117: 798-805. [Abstract] [Full Text]

Technetium 99m–Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis
Francois Rouzet, Miguel Dominguez Hernandez, Florence Hervatin, Laure Sarda-Mantel, Agnes Lefort, Xavier Duval, Liliane Louedec, Bruno Fantin, Dominique Le Guludec, and Jean-Baptiste Michel
Circulation 2008 117: 781-789. [Abstract] [Full Text]

Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing Hearts
Takeshi Yamamoto, Masafumi Yano, XiaoJuan Xu, Hitoshi Uchinoumi, Hiroki Tateishi, Mamoru Mochizuki, Tetsuro Oda, Shigeki Kobayashi, Noriaki Ikemoto, and Masunori Matsuzaki
Circulation 2008 117: 762-772. [Abstract] [Full Text]

Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk
Aruna D. Pradhan, Sanjay Shrivastava, Nancy R. Cook, Nader Rifai, Mark A. Creager, and Paul M Ridker
Circulation 2008 117: 823-831. [Abstract] [Full Text]

Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages
V. Bourlier, A. Zakaroff-Girard, A. Miranville, S. De Barros, M. Maumus, C. Sengenes, J. Galitzky, M. Lafontan, F. Karpe, K.N. Frayn, and A. Bouloumié
Circulation 2008 117: 806-815. [Abstract] [Full Text]

Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression
Andreas Goette, Alicja Bukowska, Uwe Lendeckel, Michaela Erxleben, Matthias Hammwöhner, Denis Strugala, Jan Pfeiffenberger, Friedrich-Wilhelm Röhl, Christof Huth, Matthias P.A. Ebert, Helmut U. Klein, and Christoph Röcken
Circulation 2008 117: 732-742. [Abstract] [Full Text]

Adenosine Modulates Cardiovascular Functions Through Activation of Extracellular Signal-Regulated Kinases 1 and 2 and Endothelial Nitric Oxide Synthase in the Nucleus Tractus Solitarii of Rats
Wen-Yu Ho, Pei-Jung Lu, Michael Hsiao, Hwong-Ru Hwang, Yu-Chou Tseng, Mao-Hsiung Yen, and Ching-Jiunn Tseng
Circulation 2008 117: 773-780. [Abstract] [Full Text]